{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:26:33Z","timestamp":1783617993584,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.yexmp.2012.07.003","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T12:35:18Z","timestamp":1343478918000},"page":"339-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The practical application of chimerism analyses in allogeneic stem cell transplant recipients: Blood chimerism is equivalent to marrow chimerism"],"prefix":"10.1016","volume":"93","author":[{"given":"Cocav A.","family":"Rauwerdink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Tsongalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor D.","family":"Tosteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2012.07.003_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"Antin","year":"2001","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.bmt.1701119","article-title":"Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT","volume":"21","author":"Bader","year":"1998","journal-title":"Bone Marrow Transplantation"},{"issue":"Suppl. 2","key":"10.1016\/j.yexmp.2012.07.003_bb0025","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/bmt.2008.280","article-title":"Monitoring of post-transplant remission of childhood malignancies: is there a standard?","volume":"42","author":"Bader","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0065","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3324\/haematol.2009.007765","article-title":"Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation","volume":"94","author":"Bornh\u00e4user","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/leu.2011.244","article-title":"Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation","volume":"26","author":"Breuer","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bmt.2008.155","article-title":"Lack of utility of chimerism studies obtained 2\u20133months after myeloablative hematopoietic cell transplantation for ALL","volume":"42","author":"Doney","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/leu.2010.283","article-title":"Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning","volume":"25","author":"Lange","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/bmt.2010.55","article-title":"Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT","volume":"46","author":"Mickelson","year":"2011","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0040","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.bmt.1705352","article-title":"Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation","volume":"37","author":"Miura","year":"2006","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0070","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3324\/haematol.10971","article-title":"Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation","volume":"92","author":"Mohty","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbmt.2008.12.496","article-title":"Prognostic utility of routine chimerism testing at 2 to 6months after allogeneic hematopoietic cell transplantation","volume":"15","author":"Mossallam","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/bmt.2008.89","article-title":"Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders","volume":"42","author":"Ozyurek","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2402550","article-title":"Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation","volume":"16","author":"P\u00e9rez-Sim\u00f3n","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0045","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.transproceed.2011.02.011","article-title":"Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Rupa-Matysek","year":"2011","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000077555","article-title":"Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation","volume":"112","author":"Thiede","year":"2004","journal-title":"Acta Haematologica"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/bmt.2008.167","article-title":"Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT","volume":"42","author":"Ting","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.yexmp.2012.07.003_bb0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/bmt.2010.179","article-title":"Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT","volume":"46","author":"Tobiasson","year":"2011","journal-title":"Bone Marrow Transplantation"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480012001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480012001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:47:22Z","timestamp":1757990842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480012001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0014480012001128"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2012.07.003","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The practical application of chimerism analyses in allogeneic stem cell transplant recipients: Blood chimerism is equivalent to marrow chimerism","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2012.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}